curve-stripping software package rstrip exponential stripping and parameter estimation (MicroMath Inc)
90
Structured Review
MicroMath Inc
curve-stripping software package rstrip exponential stripping and parameter estimation
Curve Stripping Software Package Rstrip Exponential Stripping And Parameter Estimation, supplied by MicroMath Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/curve-stripping+software+package+rstrip+exponential+stripping+and+parameter+estimation/curve+stripping+software+package+rstrip+exponential+stripping+and+parameter+estimation/pm15231525-52-22-31
Average 90 stars, based on 1 article reviews
Curve Stripping Software Package Rstrip Exponential Stripping And Parameter Estimation, supplied by MicroMath Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/curve-stripping+software+package+rstrip+exponential+stripping+and+parameter+estimation/curve+stripping+software+package+rstrip+exponential+stripping+and+parameter+estimation/pm15231525-52-22-31
Average 90 stars, based on 1 article reviews
curve-stripping software package rstrip exponential stripping and parameter estimation - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Concentration Assay:Article Title: Biodegradable cisplatin polymer in limb-sparing surgery for canine osteosarcoma. Article Snippet: Background: The rate of local recurrence of osteosarcoma after limb-sparing surgery in dogs and humans has been reported up to 28%.. The primary purpose of this study was to determine whether a biodegradable cisplatin-containing implant (OPLA-Pt), inserted into the limb-sparing surgery site at the time of surgery, would decrease the rate of local recurrence.. Secondary aims included evaluation of systemic toxicity associated with the release of cisplatin from the implant and identification of prognostic factors associated with limb-sparing surgery for osteosarcoma in dogs. Spectrophotometry:Article Title: Biodegradable cisplatin polymer in limb-sparing surgery for canine osteosarcoma. Article Snippet: Background: The rate of local recurrence of osteosarcoma after limb-sparing surgery in dogs and humans has been reported up to 28%.. The primary purpose of this study was to determine whether a biodegradable cisplatin-containing implant (OPLA-Pt), inserted into the limb-sparing surgery site at the time of surgery, would decrease the rate of local recurrence.. Secondary aims included evaluation of systemic toxicity associated with the release of cisplatin from the implant and identification of prognostic factors associated with limb-sparing surgery for osteosarcoma in dogs. Software:Article Title: Biodegradable cisplatin polymer in limb-sparing surgery for canine osteosarcoma. Article Snippet: Background: The rate of local recurrence of osteosarcoma after limb-sparing surgery in dogs and humans has been reported up to 28%.. The primary purpose of this study was to determine whether a biodegradable cisplatin-containing implant (OPLA-Pt), inserted into the limb-sparing surgery site at the time of surgery, would decrease the rate of local recurrence.. Secondary aims included evaluation of systemic toxicity associated with the release of cisplatin from the implant and identification of prognostic factors associated with limb-sparing surgery for osteosarcoma in dogs. Stripping Membranes:Article Title: Biodegradable cisplatin polymer in limb-sparing surgery for canine osteosarcoma. Article Snippet: Background: The rate of local recurrence of osteosarcoma after limb-sparing surgery in dogs and humans has been reported up to 28%.. The primary purpose of this study was to determine whether a biodegradable cisplatin-containing implant (OPLA-Pt), inserted into the limb-sparing surgery site at the time of surgery, would decrease the rate of local recurrence.. Secondary aims included evaluation of systemic toxicity associated with the release of cisplatin from the implant and identification of prognostic factors associated with limb-sparing surgery for osteosarcoma in dogs. |